Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06250309 · ClinicalTrials.gov registry record · NA
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
A NA study of Autoimmune Hepatitis, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06250309 is a NA study of Autoimmune Hepatitis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 48 participants, below the 219-participant average among 5 other Autoimmune Hepatitis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06250309, a NA study of Autoimmune Hepatitis, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, proof-of-concept pilot study which uses a cross-over design to compare two dietary interventions/treatments: Western Diet (WD) vs Mediterranean (MD) and impact on quality-of-life parameters in AIH. Participants will receive both treatments through two phases and will be divided into two groups.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dietary assignment
Study Locations (1)
Indiana
- IU Health University Hosptial - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-10-23 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06250309
The ClinicalTrials.gov registry entry for NCT06250309 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 5 other Autoimmune Hepatitis trials with a reported enrollment target (78% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autoimmune Hepatitis appearing as the primary indexed condition, and to 1 intervention - of which Dietary assignment is the first listed.
NCT06250309 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06250309 about?
NCT06250309 is a clinical study titled "Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients". This is a single-center, proof-of-concept pilot study which uses a cross-over design to compare two dietary interventions/treatments: Western Diet (WD) vs Mediterranean (MD) and impact on quality-of-life parameters in AIH. Participants will receive both treatments through two phases and will be divi...
What is the current status of trial NCT06250309?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-10-23. Estimated completion is 2028-12-31.
What conditions does trial NCT06250309 study?
This clinical trial studies the following conditions: Autoimmune Hepatitis.
What interventions are being tested in trial NCT06250309?
The interventions under investigation include: Dietary assignment (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06250309?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06250309 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autoimmune Hepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
RECRUITING
-
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
RECRUITING
-
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
RECRUITING
-
A Study of SIPLIZUMAB in AILD and LT Patients
RECRUITING · Phase 1
-
Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.